MOTIVATE-HfH: mHealth Biometrics for Young People With Diabetes

Sponsor
Liverpool John Moores University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04868851
Collaborator
Oxford University Hospitals NHS Trust (Other)
30
2
2
19.9
15
0.8

Study Details

Study Description

Brief Summary

The investigators aim to undertake a feasibility randomised controlled trial (RCT) to investigate whether mHealth technology, allowing biometric informed feedback and coaching on exercise and PA, can be effective in children with diabetes. The overall objective is to have an evidence-based exercise and PA intervention ready to evaluate in a future RCT.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Here for Health Only
  • Behavioral: mHealth technology assisted exercise counselling
N/A

Detailed Description

Staff from the Children's Diabetes team at Oxford University Hospitals NHS Foundation Trust will identify patients during routine multidisciplinary team (MDT) clinics. 30 young people with diabetes will be recruited and randomly assigned to one of two groups (Active control n=15, Intervention n=15). Following baseline measures all patients will then complete the 12 week Here for Health (HfH) Healthy lifestyle programme designed by the Diabetes team at Oxford University Hospitals NHS Foundation Trust. Following the initial HfH intervention period assessments will be repeated (T2) before a second 12 week intervention period is completed. Active control patients will receive no further input. The intervention group will be provided with exercise counselling and to support this they will also be provide with a wristwatch that can monitor everyday activity and their heart rate, a smartphone app and access to a website. The intervention group will also participate in 5 consultations with an exercise specialist to plan their exercise programme and be updated on their progress towards physical activity targets. Weekly text message updates will also provide feedback to the intervention group with participants able to respond to these updates. Following the second intervention period assessments will be repeated for a final time (T3). Testing at baseline and following the 2 interventions will include changes in physical activity, blood pressure, glycaemia control, body composition and diet.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
pilot, parallel group, randomised controlled trialpilot, parallel group, randomised controlled trial
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Children and Young People With Diabetes
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Here for Health only

Patients will complete the Here for Health Healthy Lifestyle intervention designed by the Paediatric Diabetes Dietitians at Oxford University Hospitals NHS Foundation Trust.

Behavioral: Here for Health Only
Patients will complete the Here for Health Healthy Lifestyle intervention designed by the Paediatric Diabetes Dietitians at Oxford University Hospitals NHS Foundation Trust.

Experimental: mHealth technology assisted exercise counselling (mHealth)

Patients will complete the Here for Health Healthy Lifestyle intervention before completing a 12 week mHealth technology assisted exercise counselling intervention. Participants will co-develop a 3-month structured exercise and PA programme, with support from an exercise specialist. All participants will have 5 exercise consultations with their exercise specialist. The intervention will be supported by 3 mHealth elements; 1) a wrist worn fitness watch, 2) a smartphone app for patients, and 3) a coaching website for the exercise specialist. The 3 elements will be synced, allowing data to be transferred between platforms.

Behavioral: mHealth technology assisted exercise counselling
Patients will complete the Here for Health intervention before completing a 3 month exercise and physical activity intervention supported by mHealth technology

Outcome Measures

Primary Outcome Measures

  1. Eligibility Rate [Through study completion, an average 32 weeks]

    Determine the number of young people referred to the paediatric diabetes team that are eligible to participate

  2. Recruitment rate [Through study completion, an average 32 weeks]

    The proportion of eligible patients who would be willing to take part in this trial

  3. Drop out [Through study completion, an average 32 weeks]

    Determine the number of young people retained at study completion (i.e., participant drop-out).

Secondary Outcome Measures

  1. Device derived adherence to structured exercise (mHealth technology assisted exercise counselling, Only) [Through study completion, an average 32 weeks]

    Number of exercise sessions per week

  2. Device derived duration of exercise (mHealth technology assisted exercise counselling, Only) [Through study completion, an average 32 weeks]

    minutes of exercise completed per session

  3. Device derived intensity of structured exercise (mHealth technology assisted exercise counselling, Only) [Through study completion, an average 32 weeks]

    intensity of exercise sessions performed (% of HR max)

  4. Device derived physical activity (GENEActiv) [Baseline, the final 2 weeks of intervention period 1 (weeks 10-12), and the final 2 weeks of intervention period 2 (weeks 22-24)]

    Minutes of low, moderate and vigorous physical activity

  5. Survey reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)) [Baseline, 4, 8 12,16, 20, 24 weeks]

    Bouts of mild, moderate and strenuous exercise lasting ≥30 minutes

  6. Height [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    Height (m)

  7. Weight [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    Weight (kg)

  8. Body composition [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    bioimpedence (fat mass and lean mass)

  9. Concentration of Hba1c [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    Hba1c

  10. Blood Lipid concentrations [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    Total cholesterol, HDL/LDL, Triglycerides

  11. Glycaemic control [Baseline, immediately following intervention period 1 (12 weeks) and the final 2 weeks of intervention period 2 (weeks 22-24))]

    Flash glucose monitoring

  12. Insulin dose [Baseline, immediately following intervention period 1 (12 weeks) and the final 2 weeks of intervention period 2 (weeks 22-24))]

    Insulin dose log

  13. Diet [Baseline and immediately following intervention 1 (12 weeks) and 2 (24 weeks)]

    Patients will be asked to complete The UK Diabetes and Diet Questionnaire (UKDDQ)

  14. Patient survey on intervention acceptability (mHealth technology assisted exercise counselling) [immediately following intervention 2 (24 weeks)]

    Study specific questionnaire

  15. Parent survey on intervention acceptability (mHealth technology assisted exercise counselling) [immediately following intervention 2 (24 weeks)]

    Study specific questionnaire

  16. Patient survey on intervention acceptability (Here for Health) [immediately following intervention 1 (12 weeks)]

    Study specific questionnaire

  17. Parent survey on intervention acceptability (Here for Health) [immediately following intervention 1 (12 weeks)]

    Study specific questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Receiving input from the Here for Health Healthy Lifestyle Programme

  • Aged 12-18 years

  • Diagnosed with type 1 diabetes

  • Type 1 diabetes diagnosis more than 1 year ago

  • Hypoglycaemic aware or on a continuous glucose monitor (CGM) with alarms

  • Willing to attend additional education on managing blood glucose and exercise

  • Diagnosed with type 2 diabetes and on a stable metformin dose for 3-months or more

  • BMI centile > 91st

  • Access to internet-enabled device for video calling

Exclusion Criteria:
  • Severe learning/behaviour difficulties

  • Severe autism

  • Unstable blood glucose levels

  • Glucose lowering medications other than metformin

  • Underlying medical conditions that contraindicate physical activity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Liverpool John Moores University Liverpool United Kingdom L33AF
2 Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom OX3 9DU

Sponsors and Collaborators

  • Liverpool John Moores University
  • Oxford University Hospitals NHS Trust

Investigators

  • Principal Investigator: Matthew Cocks, PhD, Liverpool John Moore University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Liverpool John Moores University
ClinicalTrials.gov Identifier:
NCT04868851
Other Study ID Numbers:
  • MOTIVATE HfH
First Posted:
May 3, 2021
Last Update Posted:
Jul 16, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Liverpool John Moores University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 16, 2021